Cannabis products and by products should immediately be federally reclassified from schedule 1 drugs to schedule 3 at a minimum. There is overwhelming worldwide scientific consensus confirming not only the proven and potential medical benefits of cannabis products, but also very few confirmed detrimental effects from casual consumption. The current schedule 1 classification is inhibiting any real research into the potential, either good or bad, of marijuana use. Common sense dictates that a plant that has been safely used for various purposes throughout human history should not be classified in the same category as proven poisons and carcinogens. Get this done now !



